Receive our newsletter – data, insights and analysis delivered to you
  1. News
August 18, 2015

Freudenberg acquires 75% stake in Germany’s Hemoteq

Freudenberg Medical has acquired a 75% stake in Germany-based Hemoteq from Earlybird Venture Capital and Pinova Capital, for an undisclosed amount.

surface coating

Freudenberg Medical has acquired a 75% stake in Germany-based Hemoteq from Earlybird Venture Capital and Pinova Capital, for an undisclosed amount.

Headquartered in Wurselen, Germany, Hemoteq provides surface coating technologies and related services for combination products such as drug eluting stents, coatings for catheters and cochlear implants, as well as drug-coated balloon catheters.

Under terms of the transaction, Hemoteq founders Michael Hoffmann and Roland Horres will hold the remaining shares, and will collaborate with chief financial officer Thomas Lowen, to manage the company.

"Hemoteq’s coating technology adds a key technology component to our portfolio."

Freudenberg Medical president Jorg Schneewind said: "Hemoteq’s coating technology adds a key technology component to our portfolio and represents an important milestone in our long-term strategy to provide a full suite of innovative technology services to our global medical device OEM customers."

According to Freudenberg, Hemoteq has 100 technology patents in innovative surface technologies. The firm provides comprehensive services, including the development of medical devices, regulatory approval and serial production.

Hemoteq CEO Michael Hoffmann said: "With the combination of our material and processing expertise and Hemoteq’s leading coating technologies, we can provide our customers a unique portfolio of product solutions.

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

"The long-term orientation and financial stability of Freudenberg assures our customers that we can reliably support them over long development processes and throughout their product life cycles."

Freudenberg develops and manufactures minimally invasive systems, as well as components made of silicone, thermoplastics and speciality metals. Its surfaces can be modified with active-ingredient coatings for optimal efficiency of the medical device.


Image: Hemoteq provides surface coating technologies for medical devices. Photo: courtesy of Business Wire.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU